Proteome Sciences Plc

Proteome Sciences (PRM)

Company name:Proteome Sciences Plc
EPIC:PRMTrading Currency:GBX
Market Sector:ASM7ISIN:GB0003104196
Market Segment:AMSMShare Type:DE
WWW Address: 1P
 Price Price Change [%] Bid Offer Open High Low Volume
 3.55 -0.05 [-1.39] 3.20 3.90 - - - 40,000
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 10.46 294.65 0.00 0.02 - 177.50 - 7.20 - 3.31

Proteome Sciences Key Figures

(at previous day's close)
Market Cap.10.46m
Shares In Issue294.65m
Prev. Close3.60
PE Ratio177.50 
Dividend Yield-%
EPS - basic0.02p
Dividend PS-p
Dividend Cover- 
Cash Flow PS0.27p
Return On Equity (ROE)-%
Operating Margin2.30%
PEG Factor-2.22 
EPS Growth Rate-80.00%
Dividends PS Growth Rate-%
Net Debt10.43m
Gross Gearing127.63%
Quick Assets3.47m
Net Working Capital-7.16m
Intangibles / Fixed Assets76.87%
Turnover PS1.74p
Pre-Tax Profit PS0.04p
Retained Profit PS0.02p
Cash PS0.81p
Net Cash PS-3.17p
Net Tangible Asset Value PS *-2.37p
Net Asset Value PS-0.94p
Spread0.70 (17.95%) 

Proteome Sciences Balance Sheet


Share Price Performance

Sample Period HighLow
1 week3.603.60
4 weeks3.753.35
12 weeks4.153.35
1 year7.203.31

Share Price Chart (5 years)

Proteome Sciences Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week3.60-0.05-1.393.600.003.60
4 weeks3.75-0.20-5.333.350.123.56
12 weeks3.93-0.38-9.553.350.183.96
26 weeks4.90-1.35-27.553.310.304.27
1 year7.20-3.65-50.693.310.254.84
3 years3.80-0.25-6.582.350.414.59
5 years4.50-0.95-

Proteome Sciences Key Management Ratios

Proteome Sciences Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio62.60 
PE Ratio177.50 
Tobin's Q Ratio 1.09 
Tobin's Q Ratio (excl. intangibles)2.14 
Dividend Yield-%
Market-to-Book Ratio-3.77 
Price-to-Pre-Tax Profit PS88.64 
Price-to-Retained Profit PS145.28 
Price-to-Cash Flow PS13.19 
Price-to-Sales PS2.04 
Price-to-Net Tangible Asset Value PS-1.50 
Price-to-Cash PS4.38 
Net Working Capital PS-2.43 
Price Pct to Working Capital PS-1.46%
Earnings Yield0.56%
Average PE116.70 
Years in average3 
PE to PE average152.10%

Proteome Sciences Financial Ratios

(Leverage Ratios)
Debt Ratio-65.77%
Debt-to-Equity Ratio-0.40 
Debt-to-Equity Ratio (excl. Intgbl)-0.16 
Debt-to-Equity Market Value0.11 
Net Gearing103.86%
Net Gearing (excl. Intangibles)179.05%
Gross Gearing127.63%
Gross Gearing (excl. Intangibles)220.01%
Gearing Under 1 Year116.67%
Gearing Under 1 Year (excl. Intgbl)201.12%
(Liquidity Ratios)
Net Working Capital to Total Assets-71.29%
Current Ratio0.39 
Quick Ratio (Acid Test)0.30 
Liquidity Ratio0.20 
Cash & Equiv/Current Assets52.37%
(Solvency Ratios)
Enterprise Value9.17m
CFO/Attributable Profit11.01 
Total Debt/Equity Market Value1.23 
Total Debt/Sales2.50 
Total Debt/Pre-Tax Profit108.64 
Total Debt12.82m
Total Debt/Net Current Assets-1.79%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs10 
Beta (60-Mnth)Beta (36-Mnth)

Proteome Sciences Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-%
Return On Assets (ROA)0.75%
Net Profit Margin1.40%
Assets Turnover0.54 
Return On Equity (ROE)-%
Return On Investment (ROI)-3.17%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues1.40%
(Asset Utilisation Multiples)
Shareholders Equity Turnover-1.67 
Fixed Assets Turnover0.96 
Current Assets Turnover1.22 
Net Working Capital Turnover 
Inventory Turnover5.22 
(Other Operating Ratios)
Total Assets-to-Sales1.87 
Debt Collection Period66.57Days

Proteome Sciences Dividends

Sorry No Data Available

Proteome Sciences Fundamentals

 31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)31 Dec 2021 (GBP)
pre tax profit-1.66-48.67%-0.04-0.77%0.255.15%0.122.30%m
attributable profit-1.31-38.52%0.153.20%0.306.21%0.071.40%m
retained profit-1.31-38.52%0.153.20%0.306.21%0.071.40%m
eps - basic (p)-0.44 0.05 0.10 0.02 
eps - diluted (p)-0.44 0.05 0.10 0.02 
dividends per share- - - - 

Proteome Sciences Balance Sheet

 31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)31 Dec 2021 (GBP)
 31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)31 Dec 2021 (GBP)
fixed assets fixed assets0.060.80%0.080.90%0.060.64%1.2712.63%m
intangibles intangibles4.2260.03%4.8057.40%5.1656.74%4.2241.99%m
fixed investments fixed investments--%1.3315.92%--%--%m
current assets - other current assets - other--%--%--%--%m
stocks stocks1.1516.32%0.8710.42%0.889.66%1.0910.83%m
debtors debtors0.659.22%0.495.81%0.798.67%1.0810.78%m
cash & securities cash & securities0.9613.63%0.809.56%2.2124.30%2.3923.76%m
creditors - short creditors - short10.50149.45%11.61138.86%11.96131.52%11.72116.67%m
creditors - long creditors - long0.344.88%0.404.82%0.495.41%1.1010.96%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves-3.82-54.33%-3.65-43.68%-3.36-36.93%-2.78-27.63%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Proteome Sciences Cash Flow Statement

31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)31 Dec 2021 (GBP)
Operating CF-0.500.021.580.79m
Pre-Financing CF-0.51-0.041.570.59m
Retained CF0.03-0.101.420.19m

Proteome Sciences Brokers

Evolution Securities LimitedMarket Maker(MME)Broker/DealerEVOEVBGGB21MMT
Canaccord Genuity LimitedMarket Maker(MME)Broker/DealerCANAHOARGB21001
Liberum Capital LimitedMarket Maker(MME)Broker/DealerLIBCLCAPGB21
Morgan Stanley Securities LtdMarket Maker(MME)Broker/DealerMOSTMSSEGB21
Shore Capital Stockbrokers LtdMarket Maker(MME)Broker/DealerSCAPSHOCGB21
Merrill Lynch InternationalMarket Maker(MME)Broker/DealerMLSBSNCSGB2LBIC
Winterflood Securities LtdMarket Maker(MME)Broker/DealerWINSWNTSGB2LBIC
ADVFN Advertorial
Your Recent History
Proteome S..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20220707 16:41:16